Hospital Ambroise Pairs

Paris 75010

0 studies enrolling now · 1 studies all time

What they study most

Advanced or Metastatic NRAS-mutant Melanoma

Studies at this site

• A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) — Running, not enrolling